Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...